Home
Stock
ETF
Institutional Holdings
Compound interest
Blog
Support Me
Login
Join us
Français
English
NASDAQ
/
Healthcare
/
Biotechnology
/
KTTA
Pasithea Therapeutics Corp.
KTTA
Summary
30-Y Financials
Dividend
Analyst
Peer analysis
Key metrics
Ownership / Senat
Dividend historical
Dividend payout ratio
-11.80
%
Dividend split
Date
Split
2024/01/02
1 / 20
